HLA A2601-restricted CTLs recognize a peptide antigen expressed on squamous cell carcinoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 7671230.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The CD4-CD8+ CTL (KE-4 CTL) cell line against autologous tumor cells was established in a patient with esophageal cancer. This KE-4 CTL recognized a peptide antigen on esophageal and lung squamous cell carcinomas in an HLA A2601-restricted manner, as evaluated by cytotoxicity against a panel of tumor cells, transfection experiments with HLA A2601 cDNA, and reconstitution with eluted peptides. None of the normal cells tested was lysed by this CTL. These results suggest the existence of HLA A2601-restricted CTL precursors recognizing a peptide antigen on SCC in a patient with esophageal cancer.
Medical subject headings
- Antigens, Neoplasm
- Carcinoma, Squamous Cell
- Esophageal Neoplasms
- HLA-A Antigens
- T-Lymphocytes, Cytotoxic